top of page
PoC announce-03.png

2024 PoC Acceleration Program

2024 Batch

TMU Track


    AeproMED Innovation Corp. Ltd.

✦ Auspex Diagnostics



✦ Clarius Mobile Health


    Instant NanoBiosensors Co.Ltd

✦ InVenis Biotherapies

✦ MedySapiens

✦ Neodocs

仲智數位健康股份有限公司 Co., Ltd.

    Pythia Biotech Ltd.

SCHS Track

✦ Anaut
✦ Anivance AI
✦ Approxima
✦ 矽響先創科技股份有限公司                   
    Decentralized Biotechnology Inteigence Co., Ltd.
✦ F.MED Co., Ltd.
✦ 千淥科技股份有限公司   
    FlumiLab Inc.
✦ NousQ Pte Ltd.
✦ 博想醫學科技股份有限公司   
    Pulxion Medical Technology
Qaelon Medical
✦ 睿谷科技股份有限公司
    RealBone Technology Co., Ltd.
✦ 瑟鎂科技股份有限公司

    SurgMate Co., Ltd.






秀傳療グループは台湾最大の民間病院グループで、10 の病院と3,700 以上のベッド、そして6,000 人の従業員を抱えています。 1973 年に黄明和博士によって設立されて以来、常にイノベーションと患者志向のサービスが中心にあります。 サービスが十分に行き届いていない地域に先進的な技術とサービスを提供することを使命とし、三次医療サービスに加えて、高齢者ケア、マタニティヘルス、総合的ながん治療にも対応する施設を運営しています。  2008 年にフランスのストラスブールにある Ircad を起源とする、アジア最大かつ最先端の低侵襲トレーニング センターが設立されました。80 か国以上から 12,000 人以上の医師を育成し、年間 約100 回のワークショップを開催しています。 外科研修に加えて、先進な研究センターや医療スタートアップのためのインキュベーションセンターも備えています。 イノベーションに最適な環境として、台湾の中心部に位置する鹿港工業団地に拠点を置き、医療技術スタートアップの成功に必要な幅広いリソースを提供する理想的な拠点となっています。



▸ オリエンテーションの日 

▸ マイルストーン / 目標の設定 


▸ 基本的なビジネスモジュールに関する洞察を提供するカリキュラム

▸ 病院内で健全なビジネスモデルを構築する 


▸ メンターデー

▸ 個別相談

▸ リソースのマッチング(医師、業界専門家、投資家)

Demo Day

▸ Pitch.

▸ 選抜チームのアクセラレータープログラムへの採用 

2024PoC Program Timeline
  • ✦ Why is Taiwan a good ecosystem for you to come and validate your solution for the Asia market?
    - Location: Average of 2h55m flight to six major cities in western Pacific. - Medical Resources: Collected over 20 years of digitized, single- payer medical data from NHI. - Technology: Strength in creating proprietary technology, R&D and manufacturing. - Innovation: Taiwan is focused on having an innovation-driven economy.
  • ✦ What can I expect to get out of BE PoC Accelerator Program?
    The BE PoC Accelerator Program provides the ideal opportunity for international startups to explore business opportunities in Asia. With our network of hospitals, startups can explore unmet clinical needs through needs validation, establishing a hospital pilot site, and access to medical resources. Startups interested in clinical trial, manufacturing, data access and fundraising resources will also benefit from our network across Taiwan and Asia.
  • ✦ Are there any fees for participating in this PoC program?
    The program is free for enrolled startups. There may be costs associated with teams interested in traveling to Taiwan for business opportunities, but this is not a prerequisite. However, in regard to IRB Submission, protocol discussion/ review/ writing, data collection, contact/ budget negotiation, and clinical coordination service out of the phase, might have additional fee.
  • ✦ What is the time commitment for participating in the PoC Accelerator program?
    The program runs for a 20-24 week period, but a full-time commitment is not required. The main reason for the length of the program is to facilitate the proper engagement with our hospital partners and the relevant clinicians. This is something that usually takes time and requires multiple engagements. Weekly, the time allocation for the program will roughly be about 3-5 hours depending on the course material for the week and the number of hospital engagements.
  • ✦ How can I choose the cohort that fits my business?
    Startups that apply to our program are allocated to one of our hospital partners depending on their area of focus. This is as each hospital has different areas of interest and resources to help startups. Taipei Medical University is focused on working with startups in the areas of digital health, artificial intelligence, and medical devices. Show Chwan Healthcare System is dedicated to working with startups that focus on minimally invasive surgery, robotic surgery, and smart surgical room solutions. If you are uncertain which hospital to apply for, please reach out directly to the BE team or apply to the program that you believe is most suitable and we will make any changes during the selection period.
  • ✦ Will my team get a guaranteed initial investment to participate in the PoC program?
    According to the experience from previous batches, the chances for the accelerated companies to be invested are 10%. The primary concern of the investment evaluation is whether the company can provide relevant information for us to conduct a certain degree of due diligence, while the other key aspect is the strategic synergy between BE and the company. We conduct due diligence based on the stage of the company, and the main categories include Business, Technology, Finance, Regulation, and Legal and Related Matters. In general, it will take about three months from the first meeting to the final decision of the Investment Committee. Since the strategic synergy between BE and the company is a key aspect of our investment evaluation, as a hospital VC, the progress of the collaboration between the companies and our two partner hospitals will play a critical role in due diligence.
bottom of page